famotidine has been researched along with Duodenal Reflux in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of the administration of famotidine, 20 mg BID, at early stages of gastroduodenal reflux disease (GDRD) based on a clinical and endoscopy study and treatment of patients of 0 and 1 degrees on the modified Savary-Miller scale." | 5.11 | [H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease]. ( Ianova, OB; Lazebnik, LB; Masharova, AA; Vasil'ev, IuV; Zelenkin, SA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazebnik, LB | 1 |
| Vasil'ev, IuV | 1 |
| Masharova, AA | 1 |
| Zelenkin, SA | 1 |
| Ianova, OB | 1 |
1 trial available for famotidine and Duodenal Reflux
| Article | Year |
|---|---|
[H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease].
Topics: Adolescent; Adult; Aged; Duodenogastric Reflux; Endoscopy, Gastrointestinal; Famotidine; Histamine H | 2004 |